Raymond James Financial Services Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.41M | Sell |
|
|||||
|
2024
Q2 | $1.48M | Buy |
|
|||||
|
2024
Q1 | $1.49M | Buy |
|
|||||
|
2023
Q4 | $695K | Sell |
|
|||||
|
2023
Q3 | $6.68M | Sell |
|
|||||
|
2023
Q2 | $7.31M | Sell |
|
|||||
|
2023
Q1 | $7.84M | Buy |
|
|||||
|
2022
Q4 | $387K | Buy |
|
|||||
|
2022
Q3 | $329K | Sell |
|
|||||
|
2022
Q2 | $426K | Sell |
|
|||||
|
2022
Q1 | $1.05M | Sell |
|
|||||
|
2021
Q4 | $2.21M | Sell |
|
|||||
|
2021
Q3 | $4.05M | Buy |
|
|||||
|
2021
Q2 | $2.32M | Buy |
|
|||||
|
2021
Q1 | $720K | Sell |
|
|||||
|
2020
Q4 | $647K | Sell |
|
|||||
|
2020
Q3 | $1.84M | Buy |
|
|||||
|
2020
Q2 | $1.24M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $764K | Buy |
|
|||||
|
2019
Q3 | $428K | Sell |
|
|||||
|
2019
Q2 | $850K | Buy |
|
|||||
|
2019
Q1 | $836K | Sell |
|
|||||
|
2018
Q4 | $730K | Sell |
|
|||||
|
2018
Q3 | $886K | Buy |
|
|||||
|
2018
Q2 | $343K | Buy |
|
|||||
|
2018
Q1 | $305K | Hold |
|
|||||
|
2017
Q4 | $313K | Buy |
|